1. Home
  2. CNS vs BHC Comparison

CNS vs BHC Comparison

Compare CNS & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cohen & Steers Inc

CNS

Cohen & Steers Inc

SELL

Current Price

$69.86

Market Cap

3.6B

Sector

Finance

ML Signal

SELL

Logo Bausch Health Companies Inc.

BHC

Bausch Health Companies Inc.

SELL

Current Price

$8.44

Market Cap

3.1B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CNS
BHC
Founded
1986
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.1B
IPO Year
2004
1996

Fundamental Metrics

Financial Performance
Metric
CNS
BHC
Price
$69.86
$8.44
Analyst Decision
Hold
Hold
Analyst Count
3
7
Target Price
★ $69.33
$8.40
AVG Volume (30 Days)
202.8K
★ 4.0M
Earning Date
10-15-2026
10-28-2026
Dividend Yield
★ 3.76%
N/A
EPS Growth
N/A
★ 423.08
EPS
★ 2.58
N/A
Revenue
$427,536,000.00
★ $8,724,000,000.00
Revenue This Year
$9.41
$7.43
Revenue Next Year
$5.94
N/A
P/E Ratio
$27.66
★ N/A
Revenue Growth
★ 4.07
N/A
52 Week Low
$58.39
$4.33
52 Week High
$86.56
$9.04

Technical Indicators

Market Signals
Indicator
CNS
BHC
Relative Strength Index (RSI) 42.05 67.23
Support Level $69.20 $7.86
Resistance Level $73.34 N/A
Average True Range (ATR) 2.38 0.43
MACD -0.18 0.02
Stochastic Oscillator 6.30 78.49

Price Performance

Historical Comparison
CNS
BHC

About CNS Cohen & Steers Inc

Cohen & Steers is a niche asset manager concentrating on real estate securities. The firm invests primarily in the equity shares of real estate investment trusts, with holdings in domestic and international real estate securities accounting for nearly two-thirds of its $102.5 billion in managed assets at the end of July 2026. Cohen & Steers also manages portfolios dedicated to preferred securities, utilities stocks, and other high-yield offerings. The firm's distribution is balanced among its closed-end funds, open-end funds, and institutional accounts. During the past four calendar quarters, the company garnered 39% (25%) of its managed assets (base management fees) from institutional clients, 48% (55%) from open-end funds, and 13% (20%) from closed-end funds.

About BHC Bausch Health Companies Inc.

Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.

Share on Social Networks: